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ovarian cancer apoptosis p53Abstract Elevated progesterone concentration during pregnancy and use of progesterone-like con-
traceptives are known to reduce ovarian cancers. This study was undertaken to decipher whether or
not there is any relationship between progesterone (also oestrogen)-mediated ovarian surface epi-
thelium (OSE) apoptosis and expression of p53, a cell-cycle arresting protein and potential tumour
suppressor. Immunohistochemical staining with cytokeratin conﬁrmed epithelial nature of the cells
in the OSE layer and inclusion cysts that invaginate inside stroma after ovulation takes place. The
in situ apoptosis index was determined during oestrus, and at mid and late-pregnancy stages in heif-
ers. Epithelia of both tissues exhibited signiﬁcantly high nuclear staining, suggesting that these cells
are aiming to apoptotic destruction. To further establish a role of progesterone, the OSE cells were
exposed in vitro to two concentrations of oestrogen and progesterone. It was revealed that
progesterone at both concentrations and oestrogen only at high concentration converted a large
proportion of these cells apoptotic. The stimulatory effect of progesterone (and to some extent
oestrogen) was also seen on p53 expression in the same cultivated OSE cells. The steroid dosage
dependence for apoptosis and p53 expression was also somewhat similar. Assuming that progester-
one action is mediated through p53-caused apoptosis as a mechanism to evade malignant transfor-
mation of OSE cells, p53 expression at mRNA and protein level was investigated in the OSE layer
in proximity to stroma, antrum and corpus luteum (CL). In cycling animals CL produces a large
amount of progesterone and also oestrogen to maintain the post-ovulatory cycle and to suppress
the gonadotropin production. Hence, cells undergoing re-epithelialization and which are in contact
with CL were expected to undergo maximum apoptotic modiﬁcation. Indeed we got the maximum
p53/p53 gene expression in these cells. We conclude that progesterone during cycling and pregnancy
may reduce the risk of developing ovarian cancer by ceasing cell cycle and diverting damaged and
282 S.Y. Saddickmutagenized OSE cells for apoptosis, and the process may be mediated through elevated p53
synthesis. However, it is also possible that progesterone and p53-induced apoptosis may be entirely
different cancer suppressive actions but coincidently happening together.
ª 2013 Production and hosting by Elsevier B.V. on behalf of King Saud University.1. Introduction
Ovarian cancer is one of most common and foetal types of can-
cer in the world. According to Cramer et al., 2010 ovarian can-
cer types are more than 30; in essence these types are classiﬁed
in relation to the way that cancer develops. There are three
common types of cells namely; surface epithelium, germ cells
and stromal cells. Common epithelial tumours commence their
development from cells which cover the outer surface of the
ovary. The ovarian surface epithelium (OSE) shows a high de-
gree of metaplasia transformation to a differentiated state, and
this can lead to the development of epithelial ovarian cancer
(EOC). Histologically, the OSE malignancy can be considered
to be serous (oviduct/fallopian tube-like), endometrioid (endo-
metrium-type) and mucinous (endocervical-like) adenocarci-
nomas, with serous adenocarcinoma comprising about 80%
share of the total ovarian epithelial carcinoma (Ahn et al.,
2010 and Baba et al., 2009). The cell of origin of ovarian epi-
thelial tumours is a debatable issue. According to Auersperg
and Woo (2008) high grade serous ovarian carcinoma of
OSE do not arise from the OSE layer, as was previously
thought, but it originates from a distal ﬁmbriated part of the
fallopian tube/oviduct, and is only secondarily manifested in
metastasis within the ovarian surface. The ﬁrst step in tumo-
urigenesis of the surface epithelium is the formation of epithe-
lial inclusion cysts derived from crypts or invaginations of the
OSE (Cramer andWelch, 1983). During post-ovulatory repair,
OSE cells tend to modulate to ﬁbroblast-like mesenchymal
cells with an appearance similar to the underlying stroma.
The epithelio-mesenchymal conversion of the OSE layer is
considered to be a homeostatic mechanism that helps to
accommodate trapped OSE cells after ovulation, and then to
incorporate them into the stroma as part of stromal ﬁbroblast
(Auersperg et al., 2001). Some displaced segments of damaged
OSE fragments retain the epithelial features and produce sur-
face invaginations (cleft) and inclusion cysts in the ovarian cor-
tex (Murdoch, 1994). The healing process also results in the
formation of crypts in the ovarian surface, which penetrates
the ovarian stroma, where they form inclusion cysts lined with
OSE cells (Godwin et al., 1993).
Why these otherwise non-proliferating resting OSE cells be-
come tumourigenic has been explained through the ‘‘incessant
ovulation theory’’ (Fathall, 1971), which speculates that re-
peated ovulation leads to malignancy due to frequent rupture
and repair of the damaged OSE layer. Under the inﬂuence of
mitogens and other stress factors, some of the mutagenized
cells undergo neoplasia transformation (Wong et al., 2004).
Women with multiple pregnancies or those who are on oral
contraceptives have shown reduced risks of EOC ( Risch,
1998; Ness et al., 2000). The validity of Fathalla (1971) hypoth-
esis has been challenged because progestin-only contraceptives,
which do not restrict ovulation, have been found to be as effec-
tive in suppressing malignancy as the oral ovulation-inhibitory
contraceptives. Risch (1998) suggests that the protection
gained from pregnancy is through the 8–9 months of continu-ously high progesterone levels. In vitro and in vivo analyses
have shown that progesterone inhibits regular cell cycle by
inducing apoptosis in normal and malignant human OSE cells
(Bu et al., 1997; Hu and Deng, 2000). Progesterone has also
been shown to reduce the risk of developing ovarian
carcinoma in postmenopausal women who have undergone
oestrogen and progesterone replacement therapy (Schneider
and Birkhauser, 1995). There is also growing evidence indicat-
ing an aetiological role of localized inﬂammation, which
accompanies each ovulation, with an associated release of
cytokines, mitogens and intrusion of inﬂammatory cells,
leading to genetic damage in the OSE cells (Landen et al.,
2008). It has been proposed that progesterone most
likely has a role in apoptotic elimination of such genetically
damaged OSE cells derived from inﬂammatory and mitogenic
responses, although the underlying mechanism is not fully
understood.
Apoptosis in a tissue manifests as distinct morphological
characteristics and energy dependent biochemical changes
(Elmore, 2007), that helps in normal cell turnover, develop-
ment, embryonic development etc.. Aberrations in apoptosis
lead to neurodegenerative diseases, ischaemic conditions, auto-
immune diseases and several forms of cancers, including EOC
(Baldwin et al., 1999). A key component in investigating apop-
tosis is p53, a tumour suppressor protein, also referred to as
‘‘guardian of the genome’’, is an important regulator of the cell
cycle by blocking progression through the G1 phase (Livneh
and Fishman, 1997). Either it triggers apoptotic response or
halts the cell cycle, including cyclin-dependent kinase inhibitor
p21. Both p53 and p21 were also suggested to regulate G2/M
checkpoint that is the transition from G2 to M phase. Muta-
tions in p53 or inactivation through interaction with viral or
cellular proteins are the most frequent alterations observed
in cancer cells ( Levine, 1997). p53 Gene was found to be
over-expressed as a result of repetition of ovulation trauma
each cycle (Aunoble et al., 2000).
It is unclear whether steroidal hormones, speciﬁcally pro-
gesterone, suppress OSE malignancy by activating tumour
suppressor genes, in particular p53, and direct the cells towards
apoptotic destruction from the ovulation site. Since OSE cells
also express p53 besides oestrogen and progesterone receptors,
and are exposed to changing levels of steroid hormones, this
study hypothesized that during pregnancy an accumulation
of progesterone may be a factor responsible for p53-mediated
apoptotic progression of mitogenic and mutationally damaged
OSE cells.
In this study cow was used as an animal model since this is
a mono-ovular animal that ovulates in a regular pattern, has
luteal phase similar in length to that of the human (15 days),
although the follicular phase is shorter in heifers (2–3 days).
Even though these animals spend their short life span gestating
or lactating, bovine ovarian cancer has also been reported
(Marchant, 1980), suggesting that the tumourigenic potential
of bovine OSE is similar to human OSE. Therefore, bovine
ovaries present a useful model for studying oncology of OSE
In vivo and in vitro studies on apoptosis in OSE cells 283and inclusion cysts. Normal gestation period in cattle also
averages 278–284 days.
This study was designed to test the hypothesis that preg-
nancy induces apoptosis within the OSE layer and inclusion
cysts, a process mediated through over-expression of p53,
which is under the control of high progesterone and oestrogen
level. This was achieved by (1) measuring apoptotic cell
death in inclusion cysts and OSE, (2) determining how proges-
terone and oestradiol affect cell death in vitro and (3) localiza-
tion of p53 and its expression proﬁle under progesterone
inﬂuence.
2. Materials and methods
2.1. Animals
Ovaries for histological analysis and for isolation of OSE cells
were obtained from pregnant and non-pregnant heifers from a
local abattoir. Ovaries were sorted and collected from the preg-
nant heifers at different stages of gestation (55–80 d, n= 8)
and (90–140 d, n= 8), the stage of pregnancy was determined
using foetal crown–rump length. For the control groups, ova-
ries were collected from cycling heifers (n= 8). Gestation per-
iod in heifers lasts from 278–284 days.
2.2. In vivo detection of apoptosis
In situ terminal transferase-mediated dUTP nick end labelling
(TUNEL) method was used in order to examine the effect of
pregnancy on the apoptotic activity in the epithelial cells of
the ovarian surface and inclusion cysts. Bovine ovaries were
ﬁxed in 4% paraformaldehyde and processed for histology
by standard procedures. According to the instructions of the
commercial kit (FragEL, DNA Fragmentation Detection
Kit, Colorimetric – TdT Enzyme-calbiochem, EMD Chemicals
Inc), brieﬂy, histological sections at 5 lm were pre-treated with
proteinase K at 37 C for 20 min. Endogenous peroxidase
activity was inactivated with 30% H2O2. The slides were then
covered with an equilibration buffer for 30 min before incuba-
tion with TdT enzyme for 90 min at 37 C (labelling reaction).
Sections were incubated with blocking buffer (4% BSA in
TBS) for 10 min then with peroxidase streptavidin conjugate
for 30 min. The reaction was detected with DAB. Background
counterstaining was done by using haematoxylin. Negative
controls were the sections incubated in the absence of TdT-
enzyme.
2.3. Immunolocalization of p53 and cytokeratin
In order to investigate whether the pattern of p53 distribution
is related to ovulation events, sections from ovaries of non-
pregnant heifers (n= 8) were processed for immunohisto-
chemistry (IHC) according to the manufacturer’s instructions
(Saddick 2012). The monoclonal antibody (mouse anti-p53
primary antibody; Novocastra) at 1:100 dilution in PBS was
used. Avidin–biotin peroxidase complex (ABC) method with
DAB as chromogen was used. Negative control for each exper-
iment was run by replacing the primary antibody with normal
serum. A tissue from human ovarian tumour was used as a po-
sitive control for p53 expression. Slides were counterstainedwith haematoxylin. To verify the epithelial origin of the OSE
cells and cells in the inner lining of inclusion cysts, sections
were processed for IHC staining of cytokeratin.
2.4. Microscopy and data quantiﬁcation
Staining density for apoptosis and p53 antigen was evaluated.
Cells were analysed under a magniﬁcation of 400X. A total of
eight ﬁelds from each tissue section (four sections per ovary)
were randomly selected, and approximately 100 epithelial cells
from each ﬁeld were counted. All inclusion cysts observed
within each section were analysed. Data were expressed as a
percentage of stained cells within the OSE layer and com-
pletely stained inclusion cysts.
2.5. OSE isolation and culture for in vitro studies
OSE cells were isolated from ovaries of non-pregnant heifers
(n= 14) by gently scraping off the cells from the ovarian
surface using a sterile plastic scraper. The cells were incubated
in the M199/MCDB 105 medium (1:1), containing 1 mM
L-glutamine, 100 IU/ml penicillin, 100 lg/ml streptomycin
and 10% FBS. The presence of OSE ﬂakes in the scrapings
was conﬁrmed using a phase-contrast microscope. The cells
were grown in the above culture medium poured in four
culture ﬂasks and were incubated at 37 C under 5% CO2
atmosphere. Medium was changed every 3–4 days until cul-
tures reached the conﬂuence stage (normally after 3–4 weeks).
Once the cells had grown to conﬂuence the cells were harvested
in trypsin/EDTA (0.05% trypsin and 0.02% EDTA) and
counted using a haematocytometer.
2.6. Induction of apoptosis by steroid treatment
Apoptosis was quantitatively determined using an APOPer-
centage apoptosis assay kit (Biocolor Ltd., Belfast, Ireland).
Trypsinized OSE cells (5 · 104 cells/well) were seeded in
96-well tissue culture plates in 200 ll of fresh culture medium
supplemented with 10% serum at 37 C in a humidiﬁed incu-
bator under an atmosphere of 5% CO2 in air for 24 h before
any treatment was given. The cells were then incubated with
serum free medium under the same conditions. After 24 h,
the culture medium was removed and replaced with 100 ll/well
of each treatment in the medium.
For steroid treatments, progesterone and 17b-oestradiol
(Sigma–Aldrich) were administrated in two doses (30 ng/ml
for the low does and 30 lg/ml for the high does). Levels of ste-
roids in preovulatory follicular ﬂuid reach levels of 1 lg/ml E2
and 17 lg/ml P4 (Lenton et al., 1988), it is expected that during
pregnancy progesterone levels increase 100 times comparing to
the normal cycle. We used the low does which represent the
systemic levels (range 1 ng/ml E2 and 30 ng/ml P4) (Lenton
et al., 1988) and high does that might represent the luteal pro-
gesterone during pregnancy. For positive control, OSE cells
were treated with 5 mM freshly prepared H2O2 (APOPercent-
age apoptosis assay kit recommendation). The treated
medium was discarded 30 min before the completion of the
incubation. Then the cells were incubated with 200 ll of ser-
um-free medium containing 10 ll of APOPercentage dye for
1 h. Cell surface-bound dye was extracted by lysis solution.
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microplate reader. All treatments were given in four replicates.
2.7. p53 Expression at different areas of the OSE
An in vitro study was required in order to investigate the role
of ovarian compartments in the regulation of p53 expression.
OSE cells were isolated from ovaries of non-pregnant heifers
(n= 14) from three different locations, (1) over large antral
follicles (size range 10–15 mm; n= 15), over mature corpora
lutea (17 mm; n= 7) and over stroma in positions away from
ovulatory activity. Sheets of OSE layer were removed by gentle
scraping of the ovaries’ surface using a sterilized plastic
scraper. OSE cells were quickly removed from the scraper by
placing the scraper into fresh media followed with centrifuga-
tion at 300 rpm.
2.8. Reverse transcription-PCR (RT-PCR) for determining p53
gene expression
The Tri Reagent method was applied to extract total RNA
from suspended OSE cells. Following the manufacturer’s
instructions, RNA samples were puriﬁed by phenol–
chloroform extraction and precipitated with absolute ethanol.
The amount of RNA was determined spectrophotometrically
at 260/280 nm. The PCR was carried out in a 50 ll reaction
mixture containing 25 ll AccessQuick Master Mix, 0.5 lM up-
stream primer, 0.5 lM downstream primers, 1 ll AMV Re-
verse Transcriptase and 1 lg RNA template. The customized
PCR primers used for ampliﬁcation were synthesized by Sig-
ma–Genosys on the basis of the available bovine sequences
(Table 1). The PCR conditions were as follows: 45 C for
45 min as a starting point for ﬁrst strand cDNA synthesis, fol-
lowed by 40 cycles at 95 C for 2 min, 52.8 C for 1 min, and
72 C for 1 min, respectively, and then the ﬁnal extension step
of 5 min at 72 C. After ampliﬁcation, 10 ll of the PCR prod-
ucts were separated by electrophoresis on 1.5% agarose gels
containing 0.002% ethidium bromide. The equal loading of
the RNA samples was ensured by RT-PCR analysis of a
housekeeping gene, GAPDH. Negative controls (reactions
without template) were run in parallel to verify the absence
of DNA contamination in RNA preparations.
2.9. Role of steroids in p53 regulation
To test if p53 expression in the OSE cells is regulated by ste-
roids, an immunocytochemistry (ICC) assay was performed.
OSE cells were transferred onto chamber slides (5 · 104 cells/
well) and incubated in the M199/MCDB 105 medium for
24 h at 37 C under an atmosphere of 5% CO2 in air. This
was followed by further 24 h incubation in serum free medium.
Cells were treated with either progesterone (30 ng/ml andTable 1 PCR primers for p53 and GAPDH genes, annealing tem
expression analysis.
Gene Forward primer Reverse prim
p53 50-CGTGTTTGTGCCTGTC 50-GTTTAC
GAPDH 50-GTTTGTGATGGGCGTGAACC 50-TTGGCA30 lg/ml) or 17b-oestradiol (30 ng/ml and 30 lg/ml) for 24 h.
After incubation, the cells were ﬁxed with ice-cold methanol
for 10 min and then permeabilized by Triton-X 100 solution,
incubated for 30 min with 10% normal goat serum and for
1 h with anti-p53 antibody. Cells were incubated for 30 min
with secondary goat anti-mouse antibody. Avidin–biotin per-
oxidase complex (ABC) method with DAB as chromogen
was used. Treatments were replicated in triplicates.
2.10. Statistical analysis
The Kolmogorov–Smirnov test was used in order to test
whether the data was normally distributed or not. According
to the normality test that was used, the data set for in vivo
apoptosis detection in OSE cells and inclusion cysts was not
normally distributed therefore the Kruskal–Wallis test was se-
lected as a powerful test for comparing more than two groups.
Values of in vitro studies (induction of apoptosis and p53
expression) were presented as means of three independent as-
says, data were normally distributed and therefore ANOVA
was selected as a robust test for analysing this type of data.
After a signiﬁcant ANOVA, a Tukey post hoc test was per-
formed in order to locate the signiﬁcant differences between
the groups. The Chi-square test was used to compare the total
percentages of p53 expression between three different areas.
Differences were considered to be signiﬁcant at P 6 0.05.
Analysis was done using Minitab version 15.
3. Results
3.1. Cytokeratin expression in OSE layer and inclusion cysts
The epithelial cell origin of the cells lining the inclusion cysts
was conﬁrmed by their positive anti-cytokeratin immunostain-
ing, characteristic of most types of epithelial cells (Fig. 1). The
area of the OSE around the ovary in cycling animals was com-
pletely stained with cytokeratin. Additionally, all the inclusion
cysts which were distinctly detected under microscope were
also expressing the epithelial marker cytokeratin. Most cysts
were typically lined with a single layer of epithelial cells, ﬂat
to squamous in shape.
3.2. Immunohistological staining of apoptotic cells in OSE and
inclusion cysts in pregnant and cycling heifers
After having conﬁrmed the epithelial nature of the OSE and
inclusion cyst layers, the extent of apoptosis was enumerated
in these layers at different reproductive stages. Apoptosis
positive cells by TUNEL assays were recognized according
to their staining patterns and morphological features such as
chromatin condensation on the periphery of the nucleus, and
grossly stained nucleus. Microscopic observations showed thatperature (Ta), number of cycles and cDNA size used for gene
er Ta Cycles cDNA size
GCCCACGGAT 52 C 40 233 bp
GCACCAGTAGAAGC 54 C 30 255 bp
μm μm
A B
Figure 1 Photomicrographs representing cytokeratin expression in (A) OSE cells and (B) inclusion cyst of bovine ovaries (blue arrows).
Brown staining indicates the cytokeratin expression (cytoplasmic localization). Red arrows show the negative staining in ovarian stroma
(OS) and tunica albuginea (TA) layers. A at 40X and B at 200X magniﬁcations.
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total OSE cells examined in all groups of animals; both non-
pregnant and pregnant. Tissues with relatively high apoptotic
index of 6% were found in OSE cells during 55–80 d preg-
nancy, whereas tissues collected from the 90–140 d pregnant
group of animals showed a signiﬁcant reduction in the number
of apoptotic OSE cells in proportion to total cells (2%)
(P 6 0.05). The least apoptotic index was found in the OSE
cells of the non-pregnant group (0.8%) (P 6 0.05) (Fig. 2).
When inclusion cysts were considered for such analysis, a
similar trend of apoptotic index was observed within epithelial
cells of different group of animals as was found in the case of
the OSE cells. Data analyses showed that 37% of the inclusion
cysts in the ovarian tissues from 55–80 d pregnant animals
were completely apoptotic. In fact under the microscope all
the lining cells seemed to be apoptotic (Fig. 3). Conversely,
the apoptosis analysis through the ovarian tissues from
90–140 d pregnant animals indicated that the number of com-
pletely apoptotic inclusion cysts was reduced to 10%
(P 6 0.05). Interestingly, the microscopic observations showed
that the vast majority of inclusion cysts in the ovarian tissues
of non-pregnant animals were completely healthy with less
than 2.5% of them lined with ﬂattened apoptotic cells.0
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Figure 2 Histogram representing in situ localization of apoptotic cells
pregnancy (n= 8) and 90–140 d pregnancy (n= 8) groups. Different l
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After 24 h of 30 lg/ml progesterone treatment, as shown in
(Fig. 4), the level of apoptotic cells in population of total
OSE cells reached 2-fold relative to the control (untreated
cells). Under the same conditions, the level of cell apoptosis
was approximately 1.1-fold in OSE cells treated with low dose
of progesterone (30 ng/ml). Treatment of OSE cells with low
dose of 17b-oestradiol (30 ng/ml) did not induce apoptosis
when compared with control OSE cells incubated with equiv-
alent ethanol. On the other hand, treatment with high dose
of oestrogen (30 lg/ml) resulted in 1.6-fold increase in
apoptosis, which was similar to the result of low dose of
progesterone.
3.4. Effect of steroids on p53 expression in cultured OSE cells
Since the results of cellular apoptosis revealed a direct inﬂu-
ence of progesterone and to some extent oestrogen, we wanted
to determine whether this process was associated with the in-
creased expression of p53 in the same cells. Results from
ICC revealed that low dose (30 ng/ml) of both the steroid
treatments did not induce p53 expression. However, a highpregnancy 90-140d pregnancy
OSE
IC
c
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Figure 3 Photomicrographs representing apoptotic cells in bovine OSE layer and inclusion cysts. (A and B) show apoptotic cells in OSE
and inclusion cyst of cycling group, (black arrows show the apoptotic cells with brown stained nuclei and red arrows show the negatively
stained cells). (C) Shows the TUNEL labelling in the inclusion cyst of mid pregnant group (completely stained).
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Figure 4 Histogram representing apoptosis in bovine cultured OSE cells after incubation with different treatments for 48 h. OSE cells
were incubated without treatment (control) or in the presence of steroids (17-b oestradiol or progesterone) at different doses (30 ng/ml and
30 lg/ml) or incubated with 5 mM H2O2 (positive control for apoptosis). Values for each treatment are expressed relative to the values of
the control, which was taken as unity (1). Different letters over bars indicate statistical differences between each treated group and control
(P 6 0.05). Data expressed as mean ± SEM; (three independent assays).
286 S.Y. Saddickdose of progesterone (30 lg/ml) increased p53 expression sig-
niﬁcantly over controls (P 6 0.01). Oestrogen treatment at
high dose 30 lg/ml also increased the level of p53 expression
signiﬁcantly (P 6 0.05) but to a lesser degree than the high
dose of progesterone (Fig. 5).
3.5. p53 Immunohistolocalization in cycling animals
Since both apoptosis induction and p53 expression were regu-
lated by direct hormone treatments, we aimed to detect p53
expression in different regions of the OSE layer in a cycling
animal. Microscopic observations showed that p53 expression
within the nuclei of the OSE cells was very low in most of the
areas around the ovary. Analysing the labelling index in each
area of the OSE layer; over the large antral follicles, over the
CL and over the stroma away from ovulation events showed,
that more immunoreactive cells were detected over CL than inthe other areas. The labelling index of p53 antigen was 4%
over the CL, which was signiﬁcantly higher than the number
of labelled cells, detected over the large antral follicles (1%)
(P 6 0.05). No positive stained cell for p53 was detected in
the OSE cells over the stroma (Figs. 6 and 7).
3.6. p53 Gene expression in different region of the OSE layer in
cycling animals
To understand whether differential p53 expression at different
OSE regions was due to a higher turnover of the pre-formed
p53 protein or de novo synthesis, the p53 gene expression
was monitored at the mRNA level by RT-PCR analysis. Re-
sults indicated that the level of p53 gene expression of the
OSE cells collected over the CL was higher than the equivalent
cells from other areas. The p53 gene expression of the OSE
cells collected from over the large follicles was lower than
μm
μm
μmμm
μm
A
D E
B C
Figure 6 Photomicrographs showing p53 immunostaining within the nuclei of OSE cells over different areas of the ovary. p53 expression
in the OSE cells over (A) CL, (B) large antral follicle and (C) ovarian stroma. Blue arrows show the positively stained cells (Brown nuclei).
Panel D and E show positive control for p53 immunostaining in cells lining the inclusion cysts (IC) of human ovarian tissues, A and E at
400X, B and C at 600X and D at 200X magniﬁcations.
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Figure 5 Histogram representing the percentage of p53 immunostaining after steroid treatments in cultured bovine OSE cells. Cultured
OSE cells were incubated without treatment (control) or in the presence of steroids (progesterone and 17-b oestradiol) at different doses
(30 ng/ml and 30 lg/ml) for 24 h. Control cells were incubated with serum free medium under the same conditions. Different letters over
bars indicate statistical differences between each treated group and control (P 6 0.05). Data expressed as mean ± SEM; (three
independent assays).
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ent p53 gene expression observed in the OSE cells collected
from over the stroma (Fig. 8).
4. Discussion
Elevated progesterone concentration during pregnancy and
use of progesterone-like contraceptives are known to reduce
ovarian cancers (Risch, 1998). This study was undertaken to
investigate whether or not there is a relationship between pro-
gesterone (also oestrogen)-mediated OSE apoptosis and
expression of p53. The results of the current study concluded
that progesterone during cycling and pregnancy plays a rolein suppressing ovarian cancer by ceasing cell cycle and divert-
ing damaged and mutagenized OSE cells for apoptosis, and the
process may be mediated through elevated p53 synthesis. How-
ever, it is also possible that progesterone and p53-induced
apoptosis may be entirely different cancer suppressive actions
but coincidently happening together.
The immunohistochemical analysis of the tissues revealed
that cytokeratin staining was present only in the surface epithe-
lia. Anti-cytokeratin antibody used in this test recognizes only
the epithelial cells’ cytoplasmic microﬁlaments and not the
mesenchyma, which might arise due to epithelial-mesenchymal
conversion after ovulation. Due to the fact that the inclusion
cysts were also stained, we rule out any possibility of invasion
StromaAFCL
9
8
7
6
5
4
3
2
1
0
Area of the ovary
N
um
be
r o
f P
53
 
la
be
lle
d 
ce
lls
P53 immunostaining in the OSE cells
Figure 7 Box plots representing p53 immunohistochemistry in
the OSE cells of cycling heifers (n= 8) through different regions
of the ovary (overlying corpora lutea (CL), antral follicles (AF)
and stroma). The lines of the boxes show the 25th, 50th (median)
and 75th percentiles, the whiskers show the 10th and 90th
percentiles and asterisks represent the outliers. Data are the
number of OSE labelled cells over each region for each section
(three sections/animal).
Figure 8 PCR gel showing p53 gene expression of freshly
isolated bovine OSE cells. OSE cells were collected from different
regions of the ovaries (n= 14) in relation to the underlying
compartment. Lane A. OSE cells overlying corpora lutea (n= 8),
lane B. ovarian stroma, lane C. antral follicles (n= 15) and lane
D. negative control. Total RNA was reverse transcribed and
ampliﬁed by PCR using p53 speciﬁc primers (upper panel).
Detection of GAPDH mRNA transcripts served as a positive
control for ampliﬁcation (lower panel).
288 S.Y. Saddickby ﬁbroblast-like mesenchymal cells in the cysts. The inclusion
cyst epithelium is the preferred site for metaplasia transforma-
tion and tumourigenesis, and epithelial-mesenchymal transfor-
mation is a mechanism to prevent this manifestation. Since the
objective was to demonstrate that apoptosis could be a mecha-
nism to avert malignancy in these tissues, it was necessary to
verify that the cells were of epithelial origin and not mesenchy-
mal. Using the standard TUNEL assay which recognizes apop-
totic nuclei, very high percentage of epithelial cells from
inclusion cysts during the pregnancy period (55–80 days)
acquired the staining. Although the percentage of apoptosis-
positive cells was much lower in the OSE layer than in the inner
lining of inclusion cyst, the highest frequency in this tissue
was also seen during 55–80 days pregnancy period. There were
negligible cells with nuclear stain in the cycling animals, sug-
gesting that practically no apoptosis took place in the oestrus
period. The frequency of apoptotic cells started to decrease asthe animals approached 90–140 days pregnancy. This observa-
tion was rather unexpected because the serum progesterone le-
vel reaches its maximum during late pregnancy period (Smith et
al., 1973). This indicates that serum hormone level may not re-
ﬂect the actual concentration of progesterone in the vicinity of
the ovarian surface. Until mid-pregnancy, the CL produces
progesterone, and when it starts to regress, the placenta takes
over. Because of the proximity, the effective hormonal concen-
tration around the OSE is expected to be high under the inﬂu-
ence of the CL rather than the placenta, even though both of
them might contribute some progesterone level in the blood
stream. Once the CL starts to regress, that is during mid-
pregnancy, the effective concentration starts to decline.
Treated OSE cells with oestrogen at high and progesterone
at both high and low concentrations signiﬁcantly increased the
in vitro apoptotic activity. In fact, high progesterone stimu-
lated apoptosis to nearly the same extent as positive control
(H2O2-treatment). Besides, both hormones also induced the
expression of cell-cycle arrester and apoptosis-inducer protein,
p53. We propose that progesterone, and to some extent oestro-
gen, through their receptors may up-regulate a cascade of
downstream pathways leading to cell-cycle arrest and pro-
grammed cell death, and further that p53 protein seems to
be responsible as a mediator molecule. Progesterone and oest-
rogen receptors have been localized within the bovine OSE
cells (D’Haeseleer et al., 2007, 2006; van den et al., 2002).
The results of in vitro hormonal effects paved the way to
test the actual in vivo inﬂuence. For this, p53 expression at
mRNA and protein level was examined in those regions of
OSE layer that are directly in contact with stroma, large an-
trum follicle or CL. The CL is the source of progesterone in
cycling animals, and one can expect that OSE in its proximity
would be under the progesterone inﬂuence. Antral follicle and
CL are also the source of oestrogen and they might also affect
the neighbouring OSE layer. In this situation p53 expression
should be high in only those regions of OSE which are in con-
tact with the CL or antrum. Accordingly, we found a very high
extent of p53 immunoreactivity and PCR product of p53 gene
mRNA in OSE layer overlying CL. There was some marginal
expression of p53 protein in OSE overlying antral follicles,
which is most likely due to oestrogen release. Although not
tested, we hypothesize that in the cow, induced apoptosis dur-
ing mid-pregnancy phase is due to elevated progesterone, and
is perhaps mediated through p53. The relationship between
progesterone induced anti-cancerous effects in OSE layer and
p53-mediated apoptosis and thereby evading tumourigenesis
may be purely coincidental. This is because the signals induc-
ing p53 expression have mitogenic and/or DNA damaging
activities (Corney et al., 2007) rather than steroids.
Wilcox et al. (2007) for the ﬁrst time elucidated a direct con-
tact effect of progesterone on anti-cancerous properties of cul-
tured human OSE cells. The approach was microarray-based
transcriptional proﬁling of over 22,000 transcripts (cDNAs
generated from total RNAs) of progesterone treated and un-
treated control cells. The most signiﬁcant up-regulation in
treated cells was of the enzymes and transporter proteins of
the cholesterol biosynthetic pathway, besides the progesterone
receptors, PR-A and PR-B, this in turn decreases the cell mem-
brane ﬂuidity, and such cells are less vulnerable to inﬂamma-
tory and physical damage due to ovulation.
Another microarray analysis was carried out to elucidate
p53 gene targets in cultured mouse OSE cells (Corney et al.,
In vivo and in vitro studies on apoptosis in OSE cells 2892007). It was found that two genes for miRNAs, termed
miR34-b and miR34-c were over-expressed in wild type cells.
These miRNAs were shown to ‘‘silence’’ several cancer-related
genes like Delta-like 1, Notch-1, Met, Myc, Cdk-6, Cyclin D1
etc. Mi-RNA-mediated repression of these downstream target
genes was considered to be a mechanism whereby p53 sup-
presses the tumour progression. Comparative genome hybrid-
ization and microarray proﬁling of normal and neoplastic OSE
cells was carried out to elucidate signature genes for tumour
suppression and many of them were found to be involved with
the p53 pathway (Landen et al., 2008). Mutation of p53 gene
and some other ovarian and breast tumour suppressor genes
like BRCA1 and BRCA2 are linked to ‘‘high-grade pathway’’
of malignancy due to unchecked proliferation, inhibition of
apoptosis, angiogenesis, stromal invasion, separation and sur-
vival away from the primary tumour, and implantation and
growth within new tissues.
In conclusion, progesterone and p53 seem to be associated
with the suppression of bovine EOC in both cycling and preg-
nant animals. At least two distinct mechanisms may be attrib-
uted to this phenomenon; (1) anti-inﬂammatory activity due to
progesterone-mediated increase in cholesterol and lipid biosyn-
thesis, and (2) p53-mediated cell cycle-arrest and apoptosis.
Whether these attributes are connected to each other or
whether they are two distinct events independently contribut-
ing to tumour suppression, needs to be further investigated
in future.
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